[2]
Testa, R.; Bonfigli, A.R.; Genovese, S.; De Nigris, V.; Ceriello, A. The possible role of flavonoids in the prevention of diabetic complications. Nutrients, 2016, 8, 1-13.
[3]
Krych, J.; Gebicka, L. Catalase is inhibited by flavonoids. Int. J. Biol. Macromol., 2013, 58, 148-153.
[4]
Zhang, X.; Huang, H.; Zhao, X. Effects of flavonoids-rich Chinese bayberry (Myrica rubra Sieb. et Zucc.) pulp extracts on glucose consumption in human HepG2 cells. J. Funct. Foods, 2015, 14, 144-153.
[5]
Zhang, J.; Wu, Y.; Zhao, X. Chemopreventive effect of flavonoids from Ougan (Citrus reticulata cv. Suavissima) fruit against cancer cell proliferation and migration. J. Funct. Foods, 2014, 10, 511-519.
[6]
Bahadoran, Z.; Mirmiran, P.; Azizi, F. Dietary polyphenols as potential nutraceuticals in management of diabetes: A review. J. Diabetes Metab. Disord., 2013, 12, 43.
[7]
Johnston, K.; Sharp, P.; Clifford, M.; Morgan, L. Dietary polyphenols decrease glucose uptake by human intestinal Caco-2 cells. FEBS Lett., 2005, 579, 1653-1657.
[8]
Jung, U.J.; Lee, M.K.; Jeong, K.S.; Choi, M.S. The hypoglycemic effects of hesperidin and naringin are partly mediated by hepaticglucose-regulating enzymes in C57BL/KsJ-db/db mice. J. Nutr., 2004, 134, 2499-2503.
[9]
Yeon, J.Y.; Bae, Y.J.; Kim, E.Y. Association between flavonoid intake and diabetes risk among the Koreans. Clin. Chim. Acta, 2015, 439, 225-230.
[10]
Lewalle, L. Warionia saharae Cosson. Al Biruniya, 1986, 3, 77-78.
[11]
Eddouks, M.; Ajebli, M.; Hebi, M. Ethnopharmacological survey of medicinal plants used in Daraa-Tafilalet region (Province of Errachidia), Morocco. J. Ethnopharmacol., 2017, 198, 516-530.
[12]
Evans, W.C. Trease and Evans Pharmacognosy, 14th ed; Singapore: Harcourt Brace and company, Asia Pvt. Ltd. , 1997, pp. 12-68.
[13]
Louli, V.; Ragoussis, N.; Magoulas, K. Recovery of phenolic antioxidants from wine industry by-products. Bioresour. Technol., 2004, 92, 201.
[14]
Hebi, M.; Farid, O.; Ajebli, M.; Eddouks, M. Potent antihyperglycemic and hypoglycemic effect of Tamarix articulata Vahl. in normal and streptozotocin-induced diabetic rats. Biomed. Pharmacother., 2017, 87, 230-239.
[15]
Ajebli, M.; Eddouks, M. Buxus sempervirens L improves streptozotocin-induced diabetes mellitus in rats. Cardiovasc. Hematol. Disord. Drug Targets, 2017, 17, 142-152.
[17]
Ajebli, M.; Eddouks, M. Buxus sempervirens L. improves lipid profile in diabetic rats. Cardiovasc. Hematol. Disord. Drug Targets, 2018, 18, 239-246.
[19]
Hebi, M.; Eddouks, M. Glucose lowering activity of the aqueous extract of Warionia saharae in normal and diabetic rats. Cardiovasc. Hematol. Agents Med. Chem., 2018, 16, 66-72.
[20]
Ramesh, B.K.; Maddirala, D.R.; Vinay, K.K.; Shaik, S.F.; Tiruvenkata, K.E.G.; Swapna, S.; Ramesh, B.; Rao, C.A. Antihyperglycemic and antihyperlipidemic activities of methanol: Water (4:1) fraction isolated from aqueous extract of Syzygium alternifolium seeds in streptozotocin-induced diabetic rats. Food Chem. Toxicol., 2010, 48, 1078-1084.
[21]
Yuan, M.; Konstantopoulos, N.; Lee, J. Reversal of obesity and diet induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science, 2001, 293, 1673-1677.
[23]
Evans, J.L.; Goldfine, I.D.; Maddux, B.A.; Grodsky, G.M. Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction? Diabetes, 2003, 52, 1-8.
[24]
Kregel, K.C.; Zhang, H.J. An integrated view of oxidative stress in aging: Basic mechanisms, functional effects, and pathological considerations. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2007, 292, R18-R36.
[25]
Ferreira, J.F.S.; Luthria, D.L.; Sasaki, T.; Heyerick, A. Flavonoids from artemisia annua L. as antioxidants and their potential synergism with artemisinin against malaria and cancer. Molecules, 2010, 15313570
[26]
Pereira, M.A.; Kottke, T.E.; Jordan, C.; O’Connor, P.J.; Pronk, N.P.; Carreon, R. Preventing and managing cardiometabolic risk: The logic for intervention. Int. J. Environ. Res. Public Health, 2009, 6256884
[27]
Ceballos-Coronel, M.L. Nutraceuticals in Diabetes Management; In: Yashwant, P. Eds., Handbook of nutraceuticals, volume 1.. Taylor and Francis Group, LLC: New York, 2010, pp. 207-215.